Page last updated: 2024-08-23

simvastatin and Peritoneal Carcinomatosis

simvastatin has been researched along with Peritoneal Carcinomatosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asensio-Sánchez, VM; Castresana-Jauregui, I; Hernaez-Ortega, MC1
Kang, WK; Lee, I; Lee, J; Lee, SJ; Park, C1

Other Studies

2 other study(ies) available for simvastatin and Peritoneal Carcinomatosis

ArticleYear
[Central retinal vein occlusion as the first symptom of ovarian cancer].
    Archivos de la Sociedad Espanola de Oftalmologia, 2013, Volume: 88, Issue:12

    Topics: Carcinoma; Fatal Outcome; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Middle Aged; Ovarian Neoplasms; Paraneoplastic Syndromes; Peritoneal Neoplasms; Protein S; Retinal Vein; Retinal Vein Occlusion; Simvastatin; Thrombophilia

2013
Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90α in human colorectal cancer.
    British journal of cancer, 2014, Jul-29, Volume: 111, Issue:3

    Topics: Angiogenesis Inhibitors; Angiopoietin-2; Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Cell Line, Tumor; Cell Movement; Cell Survival; Colorectal Neoplasms; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Peritoneal Neoplasms; Simvastatin; Tumor Burden; Xenograft Model Antitumor Assays

2014